Animas acquired
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/LifeScan completes its acquisition of the West Chester, Penn.-based insulin delivery system manufacturer Feb. 17. Animas, which will operate as an independent entity, expects to bring its GlucoWatch G3 continuous glucose monitoring system to market in 2006 (1"The Gray Sheet" Dec. 19, 2005, p. 3)...